Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,242 | 6,518 | 20,644 | 28,685 | 14,042 |
| Marketable Securities | N/A | 5,124 | N/A | N/A | 11,625 |
| Receivables | 1,175 | 506 | 1,221 | 1,370 | 1,406 |
| Inventories | 904 | 837 | 2,321 | 4,433 | 3,812 |
| Other current assets | 1,990 | 1,180 | 417 | 0 | 0 |
| TOTAL | $9,242 | $14,972 | $25,398 | $35,388 | $31,696 |
| Non-Current Assets | |||||
| PPE Net | 41 | 70 | 680 | 2,291 | 3,539 |
| Intangibles | 39 | 39 | 40 | 484 | 778 |
| Other Non-Current Assets | 4,195 | 4,624 | 2,804 | 5,755 | 11,335 |
| TOTAL | $4,275 | $4,733 | $3,524 | $8,530 | $15,652 |
| Total Assets | $13,517 | $19,705 | $28,922 | $43,918 | $47,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,141 |
| Accounts payable and accrued liabilities | 2,138 | 1,968 | 2,903 | 3,702 | 4,185 |
| Other current liabilities | 270 | 270 | 270 | 264 | 263 |
| TOTAL | $2,563 | $3,590 | $4,209 | $5,040 | $6,314 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,105 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 8 |
| Other Non-Current Liabilities | 4,731 | 3,417 | 4,049 | 9,156 | 11,748 |
| TOTAL | $4,731 | $3,412 | $3,813 | $7,682 | $12,482 |
| Total Liabilities | $7,294 | $7,002 | $8,022 | $12,722 | $18,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,367 | 1,363 | 858 | 555 | 533 |
| Common Shares | 65 | 65 | 65 | 63 | 54 |
| Retained earnings | -278,878 | -271,840 | -257,859 | -226,485 | -211,825 |
| Other shareholders' equity | 0 | -37 | -133 | 103 | 827 |
| TOTAL | $6,223 | $12,703 | $20,900 | $31,196 | $28,552 |
| Total Liabilities And Equity | $13,517 | $19,705 | $28,922 | $43,918 | $47,348 |